97 related articles for article (PubMed ID: 31696837)
1. Vaccine-associated kidney diseases: A narrative review of the literature.
Patel C; Shah HH
Saudi J Kidney Dis Transpl; 2019; 30(5):1002-1009. PubMed ID: 31696837
[TBL] [Abstract][Full Text] [Related]
2. Active immunization in the United States: developments over the past decade.
Dennehy PH
Clin Microbiol Rev; 2001 Oct; 14(4):872-908, table of contents. PubMed ID: 11585789
[TBL] [Abstract][Full Text] [Related]
3. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
[TBL] [Abstract][Full Text] [Related]
4. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
[TBL] [Abstract][Full Text] [Related]
5. IgA Nephropathy After SARS-CoV-2 Vaccination.
Abramson M; Mon-Wei Yu S; Campbell KN; Chung M; Salem F
Kidney Med; 2021; 3(5):860-863. PubMed ID: 34278290
[TBL] [Abstract][Full Text] [Related]
6. Minimal change disease relapse following SARS-CoV-2 mRNA vaccine.
Kervella D; Jacquemont L; Chapelet-Debout A; Deltombe C; Ville S
Kidney Int; 2021 Aug; 100(2):457-458. PubMed ID: 33964312
[No Abstract] [Full Text] [Related]
7. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?
Izzedine H; Bonilla M; Jhaveri KD
Nephrol Dial Transplant; 2021 Aug; 36(9):1565-1569. PubMed ID: 34245294
[No Abstract] [Full Text] [Related]
8. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
Leclerc S; Royal V; Lamarche C; Laurin LP
Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
[TBL] [Abstract][Full Text] [Related]
9. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.
Carr EJ; Kronbichler A; Graham-Brown M; Abra G; Argyropoulos C; Harper L; Lerma EV; Suri RS; Topf J; Willicombe M; Hiremath S
Kidney Int Rep; 2021 Sep; 6(9):2292-2304. PubMed ID: 34250319
[TBL] [Abstract][Full Text] [Related]
10. Granulomatous vasculitis after the AstraZeneca anti-SARS-CoV-2 vaccine.
Gillion V; Jadoul M; Demoulin N; Aydin S; Devresse A
Kidney Int; 2021 Sep; 100(3):706-707. PubMed ID: 34237323
[No Abstract] [Full Text] [Related]
11. De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
Bomback AS; Kudose S; D'Agati VD
Am J Kidney Dis; 2021 Oct; 78(4):477-480. PubMed ID: 34182049
[No Abstract] [Full Text] [Related]
12. Is COVID-19 vaccination unmasking glomerulonephritis?
Tan HZ; Tan RY; Choo JCJ; Lim CC; Tan CS; Loh AHL; Tien CS; Tan PH; Woo KT
Kidney Int; 2021 Aug; 100(2):469-471. PubMed ID: 34033857
[No Abstract] [Full Text] [Related]
13. Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Komaba H; Wada T; Fukagawa M
Am J Kidney Dis; 2021 Sep; 78(3):469-470. PubMed ID: 34023417
[No Abstract] [Full Text] [Related]
14. Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine.
Holzworth A; Couchot P; Cruz-Knight W; Brucculeri M
Kidney Int; 2021 Aug; 100(2):463-464. PubMed ID: 34048824
[No Abstract] [Full Text] [Related]
15. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.
D'Agati VD; Kudose S; Bomback AS; Adamidis A; Tartini A
Kidney Int; 2021 Aug; 100(2):461-463. PubMed ID: 34000278
[No Abstract] [Full Text] [Related]
16. Minimal change disease following COVID-19 vaccination: A systematic review.
Kechagias KS; Laleye JD; Drmota J; Geropoulos G; Kyrtsonis G; Zafeiri M; Triantafyllidis KK; Stathi D
PLoS One; 2024; 19(3):e0297568. PubMed ID: 38442131
[TBL] [Abstract][Full Text] [Related]
17. ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.
Campos MAG; Valois TO; Magalhães LE; Vasques LF; de Medeiros RG; Costa DMDN; Salgado Filho N; Nogueira RMDR; Neves PDMM; Silva GEB
Front Immunol; 2023; 14():1298622. PubMed ID: 38299140
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney disease following COVID-19 vaccination: a single-center retrospective study.
Chen CC; Yang SS; Hsu YJ; Sung CC; Chu P; Wu CC; Hsu SN; Wang HE; Lee DJ; Lin SH
Front Med (Lausanne); 2023; 10():1189243. PubMed ID: 37283622
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Immune-Mediated Glomerulopathies before and after SARS-CoV-2 Vaccination: A Tertiary Referral Hospital Experience.
Zamora JI; López-Martínez M; Patricio Liebana M; Leon Román JC; Bermejo S; Vergara A; Agraz I; Terrades NR; Azancot MA; Toapanta N; Gabaldon MA; Soler MJ
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983419
[TBL] [Abstract][Full Text] [Related]
20. New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria
Lo Sardo L; Parisi S; Ditto MC; De Giovanni R; Maletta F; Grimaldi S; Brussino L; Fusaro E
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
